HIGHLIGHTS
- who: Eu Jeong Ku and colleagues from the Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea have published the article: The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice, in the Journal: (JOURNAL) of 11/04/2022
- what: The authors aimed to investigate the effect of anakinra a recombinant human IL-1 receptor antagonist on the progression of atherosclerosis apolipoprotein E (ApoE-/- ) ApoE-/- (8-week male) were treated with saline (control) anakinra 10 25 and 50 mg/kg respectively (n = 10 each group). were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.